The first Macau patient was treated with CAR-T cells, and the CAR-T cell therapy center was started with the Dajiayi First Hospital

Wen, Figure/Yangcheng Evening News all -media reporter Zhang Hua correspondent Zhang Cancheng

On September 9th, the launching ceremony of the CAR-T cell therapy center affiliated to Jinan University was successfully held, providing the latest CAR-T therapy for patients with lymphoma in the South China region and the Guangdong-Hong Kong-Macao Greater Bay Area. According to the reporter's understanding, the first hospital of the University of China, as a designated treatment hospital for blood diseases in Macau, conducted the first Macau patient CAR-T cell treatment on the same day.

The CAR-T cell therapy center at the Dajiayi First Hospital was started

Deputy Dean Zheng Xiaofei of the First Affiliated Hospital introduced to reporters that CAR-T cell therapy, as the hottest research technology in the field of biomedicine, is also a hot spot for global tumor treatment research.

"The latest introduction of CAR-T cell therapy for the hospital has maintained a leading position in the field of blood tumor therapy in South China. The hospital focuses on developing cutting-edge medical technology, building high-level clinical research platforms, gathering top medical talents, and solidly promoting the high-level construction of hospitals "Dean Xu Anding of the First Affiliated Hospital of Daxia said.

The Secretary of the Secretary of the Hospital of the University of China emphasized that the hospital will give full play to the advantages of hospital resources and fully support the development of new CAR-T technology. Adhering to new technologies and new concepts, the hospital has always been at the forefront of medical technology in the Greater Bay Area and continues to work hard to escort patients.

Professor Zeng Hui, the Department of Blood Department of the First Hospital of Da Dajia, introduced car-T therapy

According to Professor Zeng Hui of the Department of Hematology of the First Hospital of Daiang, the full name of CAR-T the treatment is "chimeric antigen receptor T cell immunotherapy". The principle is to apply the patient's own T lymphocytes. Tumor antigen receptors and co -stimulating molecules, at the same time, make it in vitro, make T cells transform into a "Avengers" from "alone", and return to the patient's body again to identify and kill themselves. Tumor cells.

It is reported that, the designated treatment hospital of Patriarch, as a patient with blood diseases in Macau, will carry out the first Macau patient CAR-T cell therapy on the same day.

Source | Yangcheng Evening News · Yangcheng School

Editor -in -law | Sun Wei

- END -